Rituxan 500 MG/50 ML vial 50ML
Ended Awarded
- Contract number
- SPE2DB26FZQ81
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,932
Award facts
- Contract value 100% obligated
- $11,931.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,931.76 to DMS Pharmaceutical Group Inc. on October 29, 2025, for the supply of Rituxan 500 mg/50 ml vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the delivery to Park Ridge, IL under a firm fixed-price contract structure with an ultimate completion date of November 20, 2025. The contract was awarded without a set-aside designation, indicating that DMS Pharmaceutical Group competed in an unrestricted procurement environment.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for military healthcare facilities worldwide. The underlying IDC, designated as contract SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. Through this vehicle, DLA authorizes firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support the Department of Defense's global military medical supply requirements.
Quick answers
Who was awarded contract SPE2DB26FZQ81?
SPE2DB26FZQ81 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FZQ81 worth?
The government has obligated $11,932 on SPE2DB26FZQ81.
Is contract SPE2DB26FZQ81 an order under another contract?
Yes. SPE2DB26FZQ81 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB26FZQ81 competed?
The extent of competition for SPE2DB26FZQ81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award